Tag: Trodelvy
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...